Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 9/20 | 0.47 |
| ▸ | CFTR | P13569 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | GLA | P06280 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8140023 | 0.89 | KDM4E (0.39) | ALDH1A1HSD17B10KDM4ETSHRPOLB | |
| SCHEMBL5824031 | 0.83 | HSD17B10 (0.51) | ALDH1A1HSD17B10KDM4ETSHRPOLB | |
| SCHEMBL20503234 | 0.82 | KMT2A (0.47) | ALDH1A1RAB9ANPC1CYP3A4MEN1 | |
| SCHEMBL6353529 | 0.78 | KMT2A (0.51) | ALDH1A1HSD17B10TSHRSMN1; SMN2TDP1 | |
| SCHEMBL30445691 | 0.77 | KMT2A (0.44) | ALDH1A1RAB9ANPC1CYP3A4MEN1 | |
| SCHEMBL8138563 | 0.75 | KMT2A (0.39) | ALDH1A1HPGDRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL6430893 | 0.73 | ALDH1A1 (0.60) | ALDH1A1HSD17B10CFTRKDM4ETSHR | |
| SCHEMBL8132876 | 0.73 | MAPK1 (0.41) | ALDH1A1KDM4EPOLBHPGDRAB9A | |
| SCHEMBL10663480 | 0.73 | ALDH1A1 (0.33) | ALDH1A1HSD17B10KDM4ETSHRHPGD | |
| SCHEMBL9341204 | 0.72 | KMT2A (0.49) | ALDH1A1TSHRSMN1; SMN2L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025073990-A1 | SPF BOOSTER FOR SUNSCREEN COMPOSITION | OXFORD UNIVERSITY INOVATION LTD. (GB) | 2025-04-10 | — | — | WO | disclosed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | CoLabs International Corporation (US) | 2023-12-12 | — | — | US | disclosed |
| US-11752086-B2 | Topical formulations and methods | MYOCEPT INC. (US) | 2023-09-12 | — | — | US | disclosed |
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CoLabs International Corporation (US) | 2023-08-15 | — | — | US | disclosed |
| CN-114685851-A | Photostable compositions comprising p-alkoxyphenyl substituted acrylic Acid (APP) derivatives | 浩思特美容与个人护理创新公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20210338558-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2021-11-04 | — | — | US | disclosed |
| CN-107847422-B | Photostable compositions comprising p-alkoxyphenyl substituted acrylic Acid (APP) copolymer derivatives | 浩思特美容与个人护理创新公司 | 2020-11-27 | — | — | CN | disclosed |
| WO-2020068665-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2020-04-02 | — | — | WO | disclosed |
| WO-2018148338-A1 | TOPICAL FORMULATIONS AND METHODS | PETERS LARS ERIK (US) | 2018-08-16 | — | — | WO | disclosed |
| WO-2003070161-A2 | EMULSIFIED SKIN CARE COMPOSITION CONTAINING SALICYLIC ACID, LANOLIN OIL, AND PROPYLENE GLYCOL | ALWYN COMPANY, INC. (US) | 2003-08-28 | — | — | WO | disclosed |
| US-20030157137-A1 | Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol | ALWYN COMPANY, INC. | 2003-08-21 | — | — | US | disclosed |
| US-20030147968-A1 | Allantoin-containing preparations for administration as gels and aerosols | ALWYN COMPANY, INC. | 2003-08-07 | — | — | US | disclosed |
| WO-2003053369-A1 | ALLANTOIN-CONTAINING PREPARATIONS FOR ADMINISTRATION AS GELS AND AEROSOLS | ALWYN COMPANY, INC. (US) | 2003-07-03 | — | — | WO | disclosed |
| WO-2003041688-A1 | METHODS FOR TREATMENT OF INFLAMMATORY DISEASES | ALWYN COMPANY, INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| WO-2003041651-A2 | ALLATOIN-CONTAINING SKIN CREAM | ALWYN COMPANY, INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| US-20020054895-A1 | And at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectants | ALWYN COMPANY, INC. | 2002-05-09 | — | — | US | disclosed |
| US-20020055531-A1 | Methods for treatment of inflammatory diseases | SWEEN, MAURICE ALWYN | 2002-05-09 | — | — | US | disclosed |
| US-6376557-B1 | TRANSDERMAL SUPPLYING | ZAVERI CHANDA BHUWALKA (US) | 2002-04-23 | — | — | US | disclosed |
| WO-2001068107-A1 | HAIR RESTORATION FORMULATION | ZAVERI CHANDA BHUWALKA (US) | 2001-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11724134-B2 | Compositions containing a cellulose derived capsule with a sunscreen active agent | CUTA, ACMSD, TYR | ALDH1A1 463/4885HSD17B10 1495/4885CFTR 4286/4885 |
| US-20210338558-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | COL14A1, COL2A1, COL1A1 | ALDH1A1 3422/4885HSD17B10 2810/4885CFTR 2540/4885 |
| US-11752086-B2 | Topical formulations and methods | KRT18, ANXA3, VIP | ALDH1A1 4831/4885HSD17B10 2793/4885CFTR 522/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | ALDH1A1 1189/4885HSD17B10 3508/4885CFTR 3332/4885 |
| US-11839674-B2 | Compositions comprising silicon dioxide-based particles including one or more agents | MSN, LIPE, CUTA | ALDH1A1 1278/4885HSD17B10 3630/4885CFTR 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.